scholarly journals Prediction of hospitalization and blood transfusion requirement in patients with macroscopic hematuria

2021 ◽  
Vol 3 (4) ◽  
pp. 315-318
Author(s):  
Hasan Basri ÇETİNKAYA ◽  
Harun GÜNEŞ
Keyword(s):  
Blood Transfusion ◽  
Transfusion Requirement ◽  
Macroscopic Hematuria ◽  
Blood Transfusion Requirement

Levosimendan administration is not associated with increased risk of bleeding and blood transfusion requirement in patients undergoing off-pump coronary artery bypass grafting: a retrospective study from single center

Perfusion ◽  
2021 ◽  
pp. 026765912110490
Author(s):  
Li-hong Wang ◽  
Xiao-hong Wang ◽  
Jie-chao Tan ◽  
Li-xian He ◽  
Run-qiao Fu ◽  
...  
Keyword(s):  
Blood Transfusion ◽  
Transfusion Requirement ◽  
Artery Bypass ◽  
Postoperative Bleeding ◽  
Control Group ◽  
Chest Drainage ◽  
Off Pump ◽  
Blood Transfusion Requirement ◽  
Pump Coronary Artery Bypass ◽  
And Control

Background: Levosimendan (LEVO) is a positive inotropic drug which could increase myocardial contractility and reduce the mortality rate in cardiac surgical patients. However, Whether LEVO is associated with postoperative bleeding and blood transfusion in cardiac surgical patients is controversial. Therefore, the current study was designed to investigate the impact of LEVO administration on bleeding and blood transfusion requirement in off-pump coronary artery bypass grafting (OPCAB) patients. Methods: In a retrospective analysis, a total of 292 patients, aged 40–87 years, undergoing elective OPCAB between January 2019 and July 2019, were divided into LEVO group ( n = 151) and Control group ( n = 141). Patients in LEVO group continuously received LEVO at a rate of 0.1–0.2 μg kg−1 min−1 after anesthesia induction until 24 hours after OPCAB or patients in Control group received no LEVO. The primary outcome was postoperative chest drainage volume. The secondary outcomes were reoperation for postoperative bleeding, transfusion requirement of red blood cells (RBCs), fresh frozen plasma (FFP) and platelet concentrate (PC), etc. Comparisons of two groups were performed with the Student’s t-test or Wilcoxon-Mann-Whitney test. Results: There was no significant difference with respect to chest drainage volume ((956.29 ± 555.45) ml vs (1003.19 ± 572.25) ml, p = 0.478) and the incidence of reoperation for postoperative bleeding (1.32% vs 1.42%, p = 0.945) between LEVO group and Control group. The transfusion incidence and volume of allogeneic RBCs, FFP, and PC were comparable between two groups. Conclusions: LEVO administration was neither associated with more postoperative blood loss nor increased allogeneic blood transfusion requirement in OPCAB patients.

Impact of Miniaturization of Cardiopulmonary Bypass Circuit on Blood Transfusion Requirement in Neonatal Open-Heart Surgery

ASAIO Journal ◽  
2007 ◽  
Vol 53 (6) ◽  
pp. 662-665 ◽  
Author(s):  
Yasuhiro Kotani ◽  
Osami Honjo ◽  
Mahito Nakakura ◽  
Shinya Ugaki ◽  
Takuya Kawabata ◽  
...  
Keyword(s):  
Cardiopulmonary Bypass ◽  
Blood Transfusion ◽  
Heart Surgery ◽  
Transfusion Requirement ◽  
Open Heart Surgery ◽  
Open Heart ◽  
Blood Transfusion Requirement

Embryo transfer is a risk factor for severe postpartum hemorrhage and blood transfusion requirement

2017 ◽  
Vol 32 (6) ◽  
pp. 879-882 ◽  
Author(s):  
Shohei Noguchi ◽  
Takeshi Murakoshi ◽  
Hiroko Konno ◽  
Mitsuru Matsushita ◽  
Minako Matsumoto
Keyword(s):  
Risk Factor ◽  
Blood Transfusion ◽  
Embryo Transfer ◽  
Postpartum Hemorrhage ◽  
Transfusion Requirement ◽  
Blood Transfusion Requirement

scholarly journals Predictors of blood transfusion requirement in elective liver resection

HPB ◽  
2010 ◽  
Vol 12 (1) ◽  
pp. 50-55 ◽  
Author(s):  
Andrew J. Cockbain ◽  
Tahir Masudi ◽  
J. Peter A. Lodge ◽  
Giles J. Toogood ◽  
K. Raj Prasad
Keyword(s):  
Liver Resection ◽  
Blood Transfusion ◽  
Transfusion Requirement ◽  
Blood Transfusion Requirement

A prehabilitation protocol to reduce blood transfusion requirement in head and neck microvascular reconstructive surgery

2019 ◽  
Vol 57 (10) ◽  
pp. e39
Author(s):  
Takaaki Sato ◽  
Antonio Gagliardi-Lugo ◽  
Christopher Lloyd ◽  
Huw Jones ◽  
Victoria King ◽  
...  
Keyword(s):  
Blood Transfusion ◽  
Head And Neck ◽  
Reconstructive Surgery ◽  
Transfusion Requirement ◽  
Blood Transfusion Requirement

The Role of Iron Chelation Activity of Wheat Grass Juice in Blood Transfusion Requirement of Intermediate Thalassaemia.

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 3829-3829
Author(s):  
Soma Mukhopadhyay ◽  
Ashis Mukhopadhyay ◽  
Pinaki Ranjan Gupta ◽  
Manoj Kar ◽  
Arpita Ghosh
Keyword(s):  
Blood Transfusion ◽  
Haemoglobin Level ◽  
Crude Extract ◽  
Transfusion Requirement ◽  
Ferritin Level ◽  
Performance Status ◽  
Iron Chelator ◽  
Blood Transfusion Requirement ◽  
Transfusion Requirements ◽  
The Mean

Abstract Background: Previously it was thought that the chlorophyll of wheat grass (Triticum astevum) may be the substitute of haemoglobin of RBC having resemblance of similar structure. A group of Austrelian scientists tried to prove that wheat grass juice increases the foetal haemoglobin level 3–5 folds in intermediate thalassaemia patients. A pilot study with wheat grass juice in major thalassaemia patients were done by Dr. Marwa et al in IPGMR, Chandigarh, India. But there is no satisfactory explanation behind the reduced blood transfusion requirements after consumption of wheat grass juice for a long period. The aim of our study was to see the effect of wheat grass juice in blood transfusion requirement in intermediate thalassaemia patients and also do the biochemical analysis of the wheat grass juice. Material & Methods: During period from January 2003 to December 2006 we selected 200 intermediate thalassaemia patients (E-thalassaemia, E-Beta & Sickle thal) in the paediatric oncology department of Netaji Subhash Chandra Bose Cancer Research Institute. The age range of the patients was 1 year to 35 years (median age 18 years). The different types of thalasssaemia were E-Beta Thalassaemia 80% (160 patients), E-Thalassaemia 15% (30 patients) and Sickle Thalassaemia 5% (10 patients). When the wheat grasses were 5–7 days old, the fresh leaves including steams were made fresh juice and had given 30ml of juice daily to all our 200 patients for continuous 6 months. Wheat grass juice was analysed by column chromatography and found to be rich in oxalic acid and malic acid which might have some role in dietary absorption of iron from intestine. Beside that the wheat grass juice was found to contain a unique iron chelating property which was performed by deoxyribose degradation assay. We compared aqueous soluble extract of 5–7th day plant and our dose dependant study showed a significant iron chelating activity of crude extract in comparison to known standard iron chelator desferroxamine (DFO). The active compounds of crude extract of wheat grass may chelate catalytic iron in iron overload disorders when taking systematic dose. Result: The mean levels of haemoglobin before starting wheat grass juice were 6.2gm%. After 6months of wheat grass therapy the mean value for haemoglobin was 7.8gm% (pvalue <. 005). Twenty four patients (12%) require blood transfusion (haemoglobin < 6gm%). The performance status was improved from 60% to 80% (Karnofsky) after wheat grass treatment. The ferritin level of all patients before the study was found to be decreased significantly after wheat grass juice consumption. The mean interval between transfusion were found increased. Being a natural potent iron chelator and H2O2 quencher, it prevents the hydroxyl radical production by Fenton reaction in the RBC. Thus it may prevent the breakdown of plasma membrane of RBC and haemoglobin level becomes stable for a prolonged period. Conclusion: We may conclude that wheat grass juice is an effective alternative of blood transfusion. It’s use in intermediate thalassaemia patients should be encouraged.

Preoperative Particle and Glue Embolization of Meningiomas: Indications, Results, and Lessons Learned from 117 Consecutive Patients

2013 ◽  
Vol 73 (2) ◽  
pp. ons244-ons252 ◽  
Author(s):  
Anouk Borg ◽  
Jinendra Ekanayake ◽  
Richard Mair ◽  
Thomas Smedley ◽  
Stefan Brew ◽  
...  
Keyword(s):  
Blood Transfusion ◽  
Blood Loss ◽  
Transfusion Requirement ◽  
Lessons Learned ◽  
Direct Result ◽  
Embolic Agent ◽  
Operative Blood Loss ◽  
Indirect Measure ◽  
Blood Transfusion Requirement ◽  
Transfusion Requirements

Abstract BACKGROUND: Preoperative embolization of meningiomas remains contentious, with persisting uncertainty over the safety and efficacy of this adjunctive technique. OBJECTIVE: To evaluate the safety of presurgical embolization of meningiomas and its impact on subsequent transfusion requirement with respect to the extent of embolization and technique used. METHODS: One hundred seventeen consecutive patients between 2001 and 2010 were referred for embolization of presumed intracranial meningioma before surgical resection. Glue and/or particles were used to devascularize the tumor in 107 patients, all of whom went on to operative resection. The extent and nature of embolization-related complications, degree of angiographic devascularization, and the intraoperative blood transfusion requirements were analyzed. RESULTS: Mean blood transfusion requirement during surgery was 0.8 units per case (range, 1-14 units). Blood transfusion was significantly lower in patients whose meningiomas were completely, angiographically devascularized (P = .035). Four patients had complications as a direct result of the embolization procedure. These included intratumoral hemorrhage in 2, sixth cranial nerve palsy in 1, and scalp necrosis requiring reconstructive surgery in 1 patient. CONCLUSION: The complication rate was 3.7%. No relationship between the embolic agent and the degree of devascularization was observed. Achieving a complete devascularization resulted in a lower blood transfusion requirement, considered an indirect measure of operative blood loss. This series demonstrates that preoperative meningioma embolization is safe and may reduce operative blood loss. We present distal intratumoral injection of liquid embolic as a safe and effective alternative to more established particle embolization techniques.

Sign in / Sign up

Export Citation Format

Share Document